Clinical Trial Update: Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating mirabegron for overactive bladder symptoms in patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Parkinson Disease

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Overactive Bladder, Parkinson Disease | Phase 4 | Status: UNKNOWN